93 related articles for article (PubMed ID: 15918976)
1. [Role and mechanism of cytokines in the carcinogenesis of liver carcinoma].
Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2005 May; 13(5):378-9. PubMed ID: 15918976
[No Abstract] [Full Text] [Related]
2. TGF-beta and hepatocellular carcinoma.
Bortolami M; Cardin R; Kotsafti A; Farinati F
Hepatology; 2008 Mar; 47(3):1095; author reply 1095-6. PubMed ID: 18306219
[No Abstract] [Full Text] [Related]
3. Hypotheses on the role of transforming growth factor-beta in the onset and progression of hepatocellular carcinoma.
Dooley S; Weng H; Mertens PR
Dig Dis; 2009; 27(2):93-101. PubMed ID: 19546546
[TBL] [Abstract][Full Text] [Related]
4. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
5. [The association of abnormal activation of hepatocyte nuclear factor-kappa B with hepatocarcinogenesis].
Yao DF; Su XQ
Zhonghua Gan Zang Bing Za Zhi; 2006 Jul; 14(7):539-40. PubMed ID: 16867281
[No Abstract] [Full Text] [Related]
6. Correlation of four vascular specific growth factors with carcinogenesis and portal vein tumor thrombus formation in human hepatocellular carcinoma.
Li Q; Xu B; Fu L; Hao XS
J Exp Clin Cancer Res; 2006 Sep; 25(3):403-9. PubMed ID: 17167981
[TBL] [Abstract][Full Text] [Related]
7. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
[TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB and liver carcinogenesis.
Arsura M; Cavin LG
Cancer Lett; 2005 Nov; 229(2):157-69. PubMed ID: 16125305
[TBL] [Abstract][Full Text] [Related]
9. A crucial function of PDGF in TGF-beta-mediated cancer progression of hepatocytes.
Gotzmann J; Fischer AN; Zojer M; Mikula M; Proell V; Huber H; Jechlinger M; Waerner T; Weith A; Beug H; Mikulits W
Oncogene; 2006 May; 25(22):3170-85. PubMed ID: 16607286
[TBL] [Abstract][Full Text] [Related]
10. Feeding the flame: new research adds to role of inflammation in cancer development.
Brower V
J Natl Cancer Inst; 2005 Feb; 97(4):251-3. PubMed ID: 15713956
[No Abstract] [Full Text] [Related]
11. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
12. Antrodia cinnamomea fruiting bodies extract suppresses the invasive potential of human liver cancer cell line PLC/PRF/5 through inhibition of nuclear factor kappaB pathway.
Hsu YL; Kuo PL; Cho CY; Ni WC; Tzeng TF; Ng LT; Kuo YH; Lin CC
Food Chem Toxicol; 2007 Jul; 45(7):1249-57. PubMed ID: 17316946
[TBL] [Abstract][Full Text] [Related]
13. Refractory response to growth factors impairs liver regeneration after hepatectomy in patients with viral hepatitis.
Umeda Y; Iwagaki H; Ozaki M; Ogino T; Iwamoto T; Yoshida R; Shinoura S; Matsuda H; Sadamori H; Tanaka N; Yagi T
Hepatogastroenterology; 2009; 56(93):971-7. PubMed ID: 19760923
[TBL] [Abstract][Full Text] [Related]
14. Kallikrein-binding protein suppresses growth of hepatocellular carcinoma by anti-angiogenic activity.
Lu L; Yang Z; Zhu B; Fang S; Yang X; Cai W; Li C; Ma JX; Gao G
Cancer Lett; 2007 Nov; 257(1):97-106. PubMed ID: 17714861
[TBL] [Abstract][Full Text] [Related]
15. Dual role of mitochondrial reactive oxygen species in hypoxia signaling: activation of nuclear factor-{kappa}B via c-SRC and oxidant-dependent cell death.
Lluis JM; Buricchi F; Chiarugi P; Morales A; Fernandez-Checa JC
Cancer Res; 2007 Aug; 67(15):7368-77. PubMed ID: 17671207
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathological features of hepatocellular carcinoma evaluated by vascular endothelial growth factor expression.
Amaoka N; Osada S; Kanematsu M; Imai H; Tomita H; Tokuyama Y; Sakashita F; Nonaka K; Goshima S; Kondo H; Adachi Y
J Gastroenterol Hepatol; 2007 Dec; 22(12):2202-7. PubMed ID: 18031381
[TBL] [Abstract][Full Text] [Related]
18. The epithelial-mesenchymal transition: fact or fiction in cancer?
Giannelli G
Hepatology; 2009 Nov; 50(5):1344-6. PubMed ID: 19877297
[No Abstract] [Full Text] [Related]
19. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
20. Nuclear factor-kappaB and the hepatic inflammation-fibrosis-cancer axis.
Elsharkawy AM; Mann DA
Hepatology; 2007 Aug; 46(2):590-7. PubMed ID: 17661407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
